{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fconference-conversations-for-pharmacists-eYu14eO6","width":444,"version":"1.0","type":"rich","title":"Conference Conversations: Pharmacist Perspectives From IAS 2021","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/41ec4006-eaa3-4b1d-b819-c0094a295d83/ias-cf-podcasticon.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/9048bb00-09f1-43df-9cd6-2f8954a570e1\" height=\"200\" width=\"100%\" title=\"Conference Conversations: Pharmacist Perspectives From IAS 2021\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Hear insights from Jennifer Cocohoba, PharmD, and Jason Schafer, PharmD, MPH, on exciting new data from IAS 2021, including 2-drug regimens for ART, long-acting ART, and novel antiretrovirals, and learn how these new data influence the role of the pharmacist in caring for patients with HIV."}